BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 592846)

  • 1. Adjuvant postoperative chemotherapy with 5-fluorouracil and methotrexate: effect of schedule of administration on metastasis of 13762 mammary adenocarcinoma.
    Lee YT; Khwaja TA
    J Surg Oncol; 1977; 9(5):469-79. PubMed ID: 592846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of preoperative intralesional BCG and postoperative 5-FU chemotherapy in three adenocarcinoma lines in rats.
    Lee YT
    J Surg Oncol; 1979; 11(4):295-304. PubMed ID: 449359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo.
    McSheehy PM; Prior MJ; Griffiths JR
    Br J Cancer; 1992 Mar; 65(3):369-75. PubMed ID: 1558790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project.
    J Clin Oncol; 1994 May; 12(5):960-9. PubMed ID: 8164048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 5-fluorouracil on methotrexate transport and cytotoxicity in HT29 colon adenocarcinoma cells.
    Chen MF; Chen LT; Boyce HW
    Cancer Lett; 1995 Jan; 88(2):133-40. PubMed ID: 7874685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiating role of previously administered agents in the combination chemotherapy of breast cancer.
    Rosner D; Snyderman M; Nemoto T
    Oncology; 1979; 36(4):160-3. PubMed ID: 471428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
    Carlomagno C; Lauria R; De Laurentiis M; Arpino G; Massarelli E; Ferrara C; Milano A; Vernaglia Lombardi A; Costanzo R; Catalano G; Bianco AR; De Placido S
    Oncology; 2002; 63(3):219-25. PubMed ID: 12381900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic consequences of antitumour drug interactions: methotrexate and 5-fluorouracil in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
    Brown I; Ward HW
    Cancer Lett; 1978 Nov; 5(5):291-7. PubMed ID: 728887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of leucovorin in modulation of 5-fluorouracil with methotrexate: potentiating or reversing effect?
    Van der Wilt CL; Braakhuis BJ; Pinedo HM; De Jong M; Smid K; Peters GJ
    Int J Cancer; 1995 May; 61(5):672-8. PubMed ID: 7768641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization to low dose 5-fluorouracil. Subsequent enhancement of its systemic antitumor effect in the rat.
    Falk RE; Hardy M; Makowka L; Teodorczyk-Injeyan J; Falk JA
    J Clin Invest; 1982 Sep; 70(3):558-67. PubMed ID: 7107895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
    Heppner GH; Calabresi P
    Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronology of combined chemotherapy (5FU) and radiotherapy. II. In vivo study.
    Demange L; Carpentier Y; Loirette M; Hivet J; Rigaud C; Desoize B
    Anticancer Res; 1993; 13(6A):2181-6. PubMed ID: 8297132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative intralesional Bacillus Calmette-GuĂ©rin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
    Bogden AE; Esber HJ; Taylor DJ; Gray JH
    Cancer Res; 1974 Jul; 34(7):1627-31. PubMed ID: 4857731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sequential chemotherapy with methotrexate and 5-fluorouracil for advanced gastric cancer].
    Iwamoto S; Kimoto M; Mure T; Onuma E; Yamamoto Y; Iki K; Yoshida K; Tadaoka Y; Majima T; Kawasaki S; Kubozoe T; Tsunoda T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):541-6. PubMed ID: 9530360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma.
    Bogden AE; Esber HJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):97-100. PubMed ID: 748802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.
    Poon MA; O'Connell MJ; Wieand HS; Krook JE; Gerstner JB; Tschetter LK; Levitt R; Kardinal CG; Mailliard JA
    J Clin Oncol; 1991 Nov; 9(11):1967-72. PubMed ID: 1941055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.